NeuroOne Medical Technologies Corporation Selling Expense
NeuroOne Medical Technologies Corporation (NMTC) reported Selling Expense of $261.08 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingExpense · last filed 2026-08-13
- NeuroOne Medical Technologies Corporation selling expense for the quarter ending 2026-06-30 was $261.08K, a 74.04% increase year-over-year.
- NeuroOne Medical Technologies Corporation selling expense for the quarter ending 2026-03-31 was $199.14K, a 26.49% increase year-over-year.
- NeuroOne Medical Technologies Corporation selling expense for the quarter ending 2025-12-31 was $174.16K, a 15.01% decline year-over-year.
- NeuroOne Medical Technologies Corporation selling expense for the quarter ending 2025-09-30 was -$511.66K.
- NeuroOne Medical Technologies Corporation selling expense for fiscal 2025 was $703.57, a 99.89% decline from fiscal 2024.
- NeuroOne Medical Technologies Corporation selling expense for fiscal 2024 was $619.28K.
| Period end | Selling Expense 3 month | Selling Expense 6 month | Selling Expense 9 month | Selling Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $261.08K 10-Q · filed 2026-08-13 | $460.21K derived: sum of 2 quarters · filed 2026-08-13 | $634.37K 10-Q · filed 2026-08-13 | $122.71K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $199.14K 10-Q/A · filed 2026-06-12 | $373.29K 10-Q/A · filed 2026-06-12 | -$138.36K derived: sum of 3 quarters · filed 2026-06-12 | $11.64K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $174.16K 10-Q · filed 2026-02-17 | -$337.50K derived: sum of 2 quarters · filed 2026-02-17 | -$187.49K derived: sum of 3 quarters · filed 2026-08-13 | -$30.06K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-09-30 | -$511.66K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | -$361.65K derived: sum of 2 quarters · filed 2026-08-13 | -$204.21K derived: sum of 3 quarters · filed 2026-08-13 | $703.57 10-K · filed 2025-12-17 |
| 2025-06-30 | $150.01K 10-Q · filed 2026-08-13 | $307.44K derived: sum of 2 quarters · filed 2026-08-13 | $512.36K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $157.44K 10-Q/A · filed 2026-06-12 | $362.35K 10-Q/A · filed 2026-06-12 | ||
| 2024-12-31 | $204.92K 10-Q · filed 2026-02-17 | |||
| 2024-09-30 | $619.28K 10-K · filed 2025-12-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |